Treatment

Created:   9/25/2014
Contains:  89 items

1 2 3 4 5

Can You Teach a Teen New Tricks? Problem Solving Skills Training Improves Oral Medication Adherence in Pediatric Patients with Inflammatory Bowel Disease Participating in a...

Greenley, Rachel N.; Gumidyala, Amitha P.; Nguyen, Eve; More

Inflammatory Bowel Diseases. 21(11):2649-2657, November 2015.

Different Profile of Efficacy of Thiopurines in Ulcerative Colitis and Crohn's Disease

Rispo, Antonio; Testa, Anna; De Palma, Giovanni Domenico; More

Inflammatory Bowel Diseases. 21(11):2570-2575, November 2015.

Safety and Efficacy of an Oral Inhibitor of the Purinergic Receptor P2X7 in Adult Patients with Moderately to Severely Active Crohn's Disease: A Randomized Placebo-controlled,...

Eser, Alexander; Colombel, Jean-Frederic; Rutgeerts, Paul; More

Inflammatory Bowel Diseases. 21(10):2247-2253, October 2015.

Safety and Efficacy of an Oral Inhibitor of the Purinergic Receptor P2X7 in Adult Patients with Moderately to Severely Active Crohn's Disease: A Randomized Placebo-controlled,...

Eser, Alexander; Colombel, Jean-Frederic; Rutgeerts, Paul; More

Inflammatory Bowel Diseases. 21(10):2247-2253, October 2015.

Extent of Early Clinical Response to Infliximab Predicts Long-term Treatment Success in Active Ulcerative Colitis

Murthy, Sanjay K.; Greenberg, Gordon R.; Croitoru, Kenneth; More

Inflammatory Bowel Diseases. 21(9):2090-2096, September 2015.

Circulating Interleukin 6 and Albumin, and Infliximab Levels Are Good Predictors of Recovering Efficacy After Dose Escalation Infliximab Therapy in Patients with Loss of Response...

Suzuki, Yasuo; Matsui, Toshiyuki; Ito, Hiroaki; More

Inflammatory Bowel Diseases. 21(9):2114-2122, September 2015.

Dental Caries and Periodontal Disease in Children and Adolescents with Inflammatory Bowel Disease: A Case–Control Study

Koutsochristou, Vassiliki; Zellos, Aglaia; Dimakou, Konstantina; More

Inflammatory Bowel Diseases. 21(8):1839-1846, August 2015.

Human Placenta-derived Cells (PDA-001) for the Treatment of Moderate-to-severe Crohn's Disease: A Phase 1b/2a Study

Melmed, Gil Y.; Pandak, William M.; Casey, Kevin; More

Inflammatory Bowel Diseases. 21(8):1809-1816, August 2015.

Use of Intravenous Immunoglobulin for Patients with Inflammatory Bowel Disease with Contraindications or Who Are Unresponsive to Conventional Treatments

Merkley, Scott A.; Beaulieu, Dawn B.; Horst, Sara; More

Inflammatory Bowel Diseases. 21(8):1854-1859, August 2015.

Effect of Thalidomide on Clinical Remission in Children and Adolescents with Ulcerative Colitis Refractory to Other Immunosuppressives: Pilot Randomized Clinical Trial

Lazzerini, Marzia; Martelossi, Stefano; Magazzù, Giuseppe; More

Inflammatory Bowel Diseases. 21(8):1739-1749, August 2015.

Efficacy and Safety of Natalizumab and Vedolizumab for the Management of Crohn's Disease: A Systematic Review and Meta-analysis

Chandar, Apoorva K.; Singh, Siddharth; Murad, Mohammad Hassan; More

Inflammatory Bowel Diseases. 21(7):1695-1708, July 2015.

The Influence of Anti–tumor Necrosis Factor Agents on Hemoglobin Levels of Patients with Inflammatory Bowel Disease

Koutroubakis, Ioannis E.; Ramos-Rivers, Claudia; Regueiro, Miguel; More

Inflammatory Bowel Diseases. 21(7):1587-1593, July 2015.

Efficacy and Safety of Natalizumab and Vedolizumab for the Management of Crohn's Disease: A Systematic Review and Meta-analysis

Chandar, Apoorva K.; Singh, Siddharth; Murad, Mohammad Hassan; More

Inflammatory Bowel Diseases. 21(7):1695-1708, July 2015.

Infliximab Does Not Worsen Outcomes During Flare-ups Associated with Cytomegalovirus Infection in Patients with Ulcerative Colitis

Pillet, Sylvie; Jarlot, Camille; Courault, Mathilde; More

Inflammatory Bowel Diseases. 21(7):1580-1586, July 2015.

The Influence of Anti–tumor Necrosis Factor Agents on Hemoglobin Levels of Patients with Inflammatory Bowel Disease

Koutroubakis, Ioannis E.; Ramos-Rivers, Claudia; Regueiro, Miguel; More

Inflammatory Bowel Diseases. 21(7):1587-1593, July 2015.

Resources Utilization and Costs the Year Before and After Starting Treatment with Adalimumab in Crohn's Disease Patients

Saro, Cristina; Ceballos, Daniel; Muñoz, Fernando; More

Inflammatory Bowel Diseases. 21(7):1631-1640, July 2015.

Use of Endoscopic Ultrasound to Guide Adalimumab Treatment in Perianal Crohn's Disease Results in Faster Fistula Healing

Wiese, Dawn M.; Beaulieu, Dawn; Slaughter, James C.; More

Inflammatory Bowel Diseases. 21(7):1594-1599, July 2015.

Prognosis of Patients with Ulcerative Colitis in Sustained Remission After Thiopurines Withdrawal

Moreno-Rincón, Estefanía; Benítez, José Manuel; Serrano-Ruiz, Francisco Javier; More

Inflammatory Bowel Diseases. 21(7):1564-1571, July 2015.

IBD LIVE Case Series–Case 2: Previous Cancer in a Patient with Crohn's Disease Is It Appropriate to Use Biologics and Immunosuppressants for IBD Treatment?

Le, Peter N.; Greer, Julia B.; Oikonomou, Ioannis; More

Inflammatory Bowel Diseases. 21(6):1401-1406, June 2015.

Briakinumab for Treatment of Crohn's Disease: Results of a Randomized Trial

Panaccione, Remo; Sandborn, William J.; Gordon, Glenn L.; More

Inflammatory Bowel Diseases. 21(6):1329-1340, June 2015.

Vedolizumab for Induction and Maintenance of Remission in Ulcerative Colitis: A Cochrane Systematic Review and Meta-analysis

Mosli, Mahmoud H.; MacDonald, John K.; Bickston, Stephen J.; More

Inflammatory Bowel Diseases. 21(5):1151-1159, May 2015.

Prevention and Treatment of Venous Thromboembolism in Patients with IBD: A Trail Still Climbing

Papa, Alfredo; Papa, Valerio; Marzo, Manuela; More

Inflammatory Bowel Diseases. 21(5):1204-1213, May 2015.

Pharmacokinetics and Exposure–Efficacy Relationship of Adalimumab in Pediatric Patients with Moderate to Severe Crohn's Disease: Results from a Randomized, Multicenter, Phase-3...

Sharma, Shringi; Eckert, Doerthe; Hyams, Jeffrey S.; More

Inflammatory Bowel Diseases. 21(4):783-792, April 2015.

Overexpression of miR-595 and miR-1246 in the Sera of Patients with Active Forms of Inflammatory Bowel Disease

Krissansen, Geoffrey W.; Yang, Yi; McQueen, Fiona M.; More

Inflammatory Bowel Diseases. 21(3):520-530, March 2015.

  • Open Access

Serum C-reactive Protein and CRP Genotype in Pediatric Inflammatory Bowel Disease: Influence on Phenotype, Natural History, and Response to Therapy

Henderson, Paul; Kennedy, Nicholas A.; Van Limbergen, Johan E.; More

Inflammatory Bowel Diseases. 21(3):596-605, March 2015.

Short-term Effect of Infliximab Is Reflected in the Clot Lysis Profile of Patients with Inflammatory Bowel Disease: A Prospective Study

Bollen, Lize; Vande Casteele, Niels; Peeters, Miet; More

Inflammatory Bowel Diseases. 21(3):570-578, March 2015.

Necrotizing Enterocolitis: A Clinical Review on Diagnostic Biomarkers and the Role of the Intestinal Microbiota

Niemarkt, Hendrik J.; de Meij, Tim G. J.; van de Velde, Mirjam E.; More

Inflammatory Bowel Diseases. 21(2):436-444, February 2015.

Validation of Gene Expression Biomarker Analysis for Biopsy-based Clinical Trials in Crohn's Disease

Boland, Brigid S.; Boyle, David L.; Sandborn, William J.; More

Inflammatory Bowel Diseases. 21(2):323-330, February 2015.

Impact of Timing and Duration of Thiopurine Treatment on First Perianal Surgery in Crohn's Disease: UK Population-based Study (1995–2009)

Chhaya, Vivek; Saxena, Sonia; Cecil, Elizabeth; More

Inflammatory Bowel Diseases. 21(2):385-391, February 2015.

Role for Therapeutic Drug Monitoring During Induction Therapy with TNF Antagonists in IBD: Evolution in the Definition and Management of Primary Nonresponse

Papamichael, Konstantinos; Gils, Ann; Rutgeerts, Paul; More

Inflammatory Bowel Diseases. 21(1):182-197, January 2015.

Involvement of Heat Shock Protein A4/Apg-2 in Refractory Inflammatory Bowel Disease

Adachi, Teppei; Sakurai, Toshiharu; Kashida, Hiroshi; More

Inflammatory Bowel Diseases. 21(1):31-39, January 2015.

Costs and Resource Utilization for Diagnosis and Treatment During the Initial Year in a European Inflammatory Bowel Disease Inception Cohort: An ECCO-EpiCom Study

Burisch, Johan; Vardi, Hillel; Pedersen, Natalia; More

Inflammatory Bowel Diseases. 21(1):121-131, January 2015.

Factors Associated with Durable Response to Infliximab in Crohn's Disease 5 Years and Beyond: A Multicenter International Cohort

Juillerat, Pascal; Sokol, Harry; Froehlich, Florian; More

Inflammatory Bowel Diseases. 21(1):60-70, January 2015.

Splitting a Therapeutic Dose of Thioguanine May Avoid Liver Toxicity and Be an Efficacious Treatment for Severe Inflammatory Bowel Disease: A 2-Center Observational Cohort Study

Pavlidis, Polychronis; Ansari, Azhar; Duley, John; More

Inflammatory Bowel Diseases. 20(12):2239-2246, December 2014.

eHealth: Individualization of Mesalazine Treatment Through a Self-managed Web-based Solution in Mild-to-moderate Ulcerative Colitis

Pedersen, Natalia; Thielsen, Peter; Martinsen, Lars; More

Inflammatory Bowel Diseases. 20(12):2276-2285, December 2014.

Anemia in a Population-based IBD Cohort (ICURE): Still High Prevalence After 1 Year, Especially Among Pediatric Patients

Sjöberg, Daniel; Holmström, Tommy; Larsson, Märit; More

Inflammatory Bowel Diseases. 20(12):2266-2270, December 2014.

Barriers and Facilitators to Successful Transition from Pediatric to Adult Inflammatory Bowel Disease Care from the Perspectives of Providers

Paine, Christine W.; Stollon, Natalie B.; Lucas, Matthew S.; More

Inflammatory Bowel Diseases. 20(11):2083-2091, November 2014.

Tumor Necrosis Factor-Alpha Antagonists Twenty Years Later: What Do Cochrane Reviews Tell Us?

Akobeng, Anthony A.; Sandborn, William J.; Bickston, Stephen J.; More

Inflammatory Bowel Diseases. 20(11):2132-2141, November 2014.

IBD LIVE Case Series—Case 1: Smoking, a Controversial but Effective Treatment for Ulcerative Colitis

Iskandar, Heba; Greer, Julia B.; Schraut, Wolfgang H.; More

Inflammatory Bowel Diseases. 20(10):1696-1701, October 2014.

Retrospective Cohort Study of Methotrexate Use in the Treatment of Pediatric Crohn's Disease

Sunseri, Whitney; Hyams, Jeffrey S.; Lerer, Trudy; More

Inflammatory Bowel Diseases. 20(8):1341-1345, August 2014.

AST-120 (Spherical Carbon Adsorbent) in the Treatment of Perianal Fistulae in Mild-to-Moderate Crohn's Disease: FHAST-1, a Phase 3, Multicenter, Placebo-controlled Study

Reinisch, Walter; Travis, Simon; Hanauer, Stephen; More

Inflammatory Bowel Diseases. 20(5):872-881, May 2014.

Safety and Effectiveness of Long-term Allopurinol–Thiopurine Maintenance Treatment in Inflammatory Bowel Disease

Hoentjen, Frank; Seinen, Margien L.; Hanauer, Stephen B.; More

Inflammatory Bowel Diseases. 19(2):363-369, February 2013.

Recommendations for the treatment of Crohn's disease with tumor necrosis factor antagonists: An expert consensus report

Feagan, Brian G.; Lémann, Marc; Befrits, Ragnar; More

Inflammatory Bowel Diseases. 18(1):152-160, January 2012.

Long-term outcome of treatment with infliximab in pediatric-onset Crohn's disease: A population-based study

Crombé, Valérie; Salleron, Julia; Savoye, Guillaume; More

Inflammatory Bowel Diseases. 17(10):2144-2152, October 2011.

1 2 3 4 5